In view of the current COVID-19 pandemic, Taiwan’s Brain Navi has recently built a new robot to carry out autonomous nasal swab tests to avoid cross-infection, with the goal of protecting healthcare staff and reducing stress on health systems. The company , founded in 2015, says it is "Focused on the design and development of a medical device capable of assisting surgeons during their routine surgical interventions."
The newly built Brain Navi Nasal Swab Robot aims to minimize personnel-patient interaction at the point of testing for highly infectious diseases by autonomously handling and gathering patient samples in a secure way.
At the Bio Asia Taiwan 2020 exhibition at the end of July the Brain Navi Nasal Swab Robot was first shown in public. In the US FDA for Emergency Use Authorization (EUA) and Taiwan TFDA, the robot 's application review of the clinical trial of the Ministry of Health and Welfare in Taiwan has been approved and the company is in the process of approval.
THE LARGER TREND
Considering the highly contagious nature of the COVID-19 virus, minimizing human interaction is one way of reducing the spread of coronavirus and technology such as the use of robots to perform such routine activities will not only minimize the risks of infection for healthcare workers and personnel, but also minimize the use of valuable workforce.
For example, Omron introduced an LD-UVC robot that autonomously navigates and disinfects premises including high-touch areas by removing 99.90% of bacteria and viruses — both airborne and droplet — by providing precise UVC energy dosage, MobiHealthNews stated. Read More From Source